(Q24187204)

8

0 references

Lorenzo Maggi

object named as

Lorenzo Maggi

3

0 references

author name string

Francesca Nava

1

0 references

Francesca Ghilotti

2

0 references

Gulen Hatemi

4

0 references

Alessandra Del Bianco

5

0 references

Chiara Merlo

Cochrane Database of Systematic Reviews

6

0 references

publication date

18 December 2014

0 references

published in

0 references

cites work

[Neurological involvement in Behçet's disease. 154 cases from a cohort of 925 patients and review of the literature]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Epilepsy and Behçet's disease: cortical and hippocampal involvement in Brazilian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Neurological involvement in Behçet's disease: evaluation of 67 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Behçet's syndrome: a report of 41 patients with emphasis on neurological manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Neurological manifestations of Behçet's disease in Japan: a study of 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Pediatric Behcet's disease and thromboses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Neuro-Behçet's disease (isolated cerebral thrombophlebitis excluded). Clinical pattern, prognostic factors, treatment and long term follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Cerebral venous thrombosis in Behçet's disease: clinical study and long-term follow-up of 25 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Behçet's syndrome: a multidisciplinary approach to clinical care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Cerebral venous thrombosis in Behçet's disease compared to those associated with other etiologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Neuro-Behçet's disease: epidemiology, clinical characteristics, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Anti-TNF agents for Behçet's disease: analysis of published data on 369 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Diagnosis and treatment of cerebral vasculitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Rituximab in intractable ocular lesions of Behcet's disease; randomized single-blind control study (pilot study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Rilonacept and canakinumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

HLA-B*51 and Behçet Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

EULAR recommendations for the management of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Low-dose weekly methotrexate for progressive neuropsychiatric manifestations in Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Diagnosis and management of Neuro-Behçet's disease: international consensus recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Central nervous system symptoms in a population of Behçet's disease patients with refractory uveitis treated with cyclosporine A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Effect of infliximab on gene expression profiling in Behcet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Central nervous system symptoms in patients with Behçet disease receiving cyclosporine therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

A double-blind trial of depot corticosteroids in Behçet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Interferon-alpha 2a treatment of neuro-Behcet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Chlorambucil in the treatment of uveitis and meningoencephalitis of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Infliximab for the treatment of Neuro-Behçet's disease: a case series and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Pharmacotherapy for Behcet's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Behçet's disease and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Adverse effects of biologics: a network meta-analysis and Cochrane overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Behçet's disease: diagnostic and prognostic aspects of neurological involvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Uveitis in Behçet disease: an analysis of 880 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Clinical characteristics of pediatric-onset neuro-Behçet disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Behçet syndrome: is it one condition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Criteria for Behçet's disease with reflections on all disease criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Immunosuppressants reduce venous thrombosis relapse in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Cerebral venous thrombosis in Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

Neurologic Involvement in Behçet's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Seven-year follow-up of neurologic involvement in Behçet syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Low dose MTX for progressive neuro-Behçet's disease. A follow-up study for 4 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

One year study of efficacy and safety of infliximab in the treatment of patients with ocular and neurological Behçet's disease refractory to standard immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

MRI findings of neuro-Behcet’s disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Tocilizumab treatment for neuro-Behcet's disease, the first report

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Infliximab monotherapy in neuro-Behçet's disease: four year follow-up in a long-standing case resistant to conventional therapies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

[Neurological manifestations of Behcet's disease: 22 cases among 170 patients]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Neurological manifestations of Behçet's disease: evaluation of 40 patients treated by cyclophosphamide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Neuro-Behcet’s disease in Iraq: a study of 40 patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Neurological complications in Behçet's syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021

Clinical characteristics and course of spinal cord involvement in Behçet's disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD010729.PUB2

7 January 2021